Journal - CNS & Neurological Disorders - Drug Targets

Impact Factor

Current: 2.7
5 - Year: 2.9

Ranking & Category

193rd of 261 in Neurosciences
166th of 261 in Pharmacology & Pharmacy

Topic(s) Covered

3 Topic(s)

View

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted & Indexed in:

BIOSIS Previews BIOSIS Reviews Reports and Meetings British Library Cabell's Directory/Journalytics Cambridge Scientific Abstracts (CSA)/ProQuest Chemical Abstracts Service/SciFinder CNKI Scholar Current Contents® - Clinical Medicine EBSCO EMBASE EMBiology Essential Science Indicators Genamics Journal Seek Google Scholar Index Copernicus Index Medicus J-Gate Journal Citation Reports/Science Edition JournalTOCs MediaFinder®-Standard Periodical Directory MEDLINE/PubMed Norwegian Register OpenAire PsycINFO PubsHub QOAM Science Citation Index Expanded™ (SciSearch®) Scilit Scopus Suweco CZ Ulrich's Periodicals Directory

Archiving and Copyright:

Portico Sherpa Romeo

Journal Database:

Dimensions

COPE Compliant

Archived in

Endorsement(s)

"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

Special Issue(s) - In-Press

Brain Imaging and Automatic Analysis in Neurological and Psychiatric diseases
Guest Editor(s): Yu-Dong Zhang, Ti-Fei Yuan, Zheng-Chao Dong
Tentative Publication Date: May, 2016
Submit Abstract via Email